CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology

被引:36
|
作者
Gu, Jiangyong [1 ]
Gui, Yuanshen [1 ]
Chen, Lirong [1 ]
Yuan, Gu [1 ]
Xu, Xiaojie [1 ]
机构
[1] Peking Univ, Beijing Natl Lab Mol Sci, State Key Lab Rare Earth Mat Chem & Applicat, Coll Chem & Mol Engn, Beijing 100871, Peoples R China
来源
JOURNAL OF CHEMINFORMATICS | 2013年 / 5卷
关键词
Cardiovascular disease; Drug discovery; Network pharmacology; Molecular docking; Virtual screening; Herbal formula; Natural products; Medicinal herbs; Traditional Chinese medicine; MULTITARGET DRUGS; NATURAL-PRODUCTS; MAGIC BULLETS; TARGET; INTEGRATION; MEDICINE; HIT;
D O I
10.1186/1758-2946-5-51
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Background: Cardiovascular disease (CVD) is the leading cause of death and associates with multiple risk factors. Herb medicines have been used to treat CVD long ago in china and several natural products or derivatives (e. g., aspirin and reserpine) are most common drugs all over the world. The objective of this work was to construct a systematic database for drug discovery based on natural products separated from CVD-related medicinal herbs and to research on action mechanism of herb medicines. Description: The cardiovascular disease herbal database (CVDHD) was designed to be a comprehensive resource for virtual screening and drug discovery from natural products isolated from medicinal herbs for cardiovascular-related diseases. CVDHD comprises 35230 distinct molecules and their identification information (chemical name, CAS registry number, molecular formula, molecular weight, international chemical identifier (InChI) and SMILES), calculated molecular properties (AlogP, number of hydrogen bond acceptor and donors, etc.), docking results between all molecules and 2395 target proteins, cardiovascular-related diseases, pathways and clinical biomarkers. All 3D structures were optimized in the MMFF94 force field and can be freely accessed. Conclusions: CVDHD integrated medicinal herbs, natural products, CVD-related target proteins, docking results, diseases and clinical biomarkers. By using the methods of virtual screening and network pharmacology, CVDHD will provide a platform to streamline drug/lead discovery from natural products and explore the action mechanism of medicinal herbs. CVDHD is freely available at http://pkuxxj.pku.edu.cn/CVDHD.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] The role of pharmacology in drug discovery
    Fredholm, BB
    Fleming, WW
    Vanhoutte, PM
    Godfraind, T
    NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (03) : 237 - 238
  • [32] Toxins in Drug Discovery and Pharmacology
    Peigneur, Steve
    Tytgat, Jan
    TOXINS, 2018, 10 (03):
  • [33] Remyelination: drug discovery and pharmacology
    Lairson, L.
    GLIA, 2015, 63 : E24 - E24
  • [34] The role of pharmacology in drug discovery
    Bertil B. Fredholm
    William W. Fleming
    Paul M. Vanhoutte
    Théophile Godfraind
    Nature Reviews Drug Discovery, 2002, 1 : 237 - 238
  • [35] Drug Discovery for Improvement of Chronic Kidney Disease and Cardiovascular Disease
    Ishizawa, Keisuke
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (09): : 1347 - 1352
  • [36] C2Maps: a network pharmacology database with comprehensive disease-gene-drug connectivity relationships
    Huang, Hui
    Wu, Xiaogang
    Pandey, Ragini
    Li, Jiao
    Zhao, Guoling
    Ibrahim, Sara
    Chen, Jake Y.
    BMC GENOMICS, 2012, 13
  • [37] C2Maps: a network pharmacology database with comprehensive disease-gene-drug connectivity relationships
    Hui Huang
    Xiaogang Wu
    Ragini Pandey
    Jiao Li
    Guoling Zhao
    Sara Ibrahim
    Jake Y Chen
    BMC Genomics, 13
  • [38] INTERVIEW Drug discovery and development in the field of cardiovascular disease
    Hemsley, Alexandra
    Greenlee, William
    FUTURE MEDICINAL CHEMISTRY, 2013, 5 (04) : 375 - 376
  • [39] Angiotensin II receptors and drug discovery in cardiovascular disease
    Dasgupta, Chiranjib
    Zhang, Lubo
    DRUG DISCOVERY TODAY, 2011, 16 (1-2) : 22 - 34
  • [40] Folk Herbal Medicine and Drug Discovery
    Bashir, Anbreen
    ECONOMIC BOTANY, 2021, 75 (02) : 177 - 178